Emerging biotech firm aims to marry tissue engineering with orthopaedics
This article was originally published in Clinica
Executive Summary
The automated cell and tissue engineering system (ACTES) developed by Octane Biotech has myriad possible applications, from skin grafts to implants – but its real advantage is its scalability.